2.92 USD
▼-0.04-6.11%
盘后 3.08 -0.96%
2026-08-03
市值
$35.92M
市盈率
—
EPS
-0.01
股息率
—
52 周区间
2.73 – 16.25
成交量
81.79K
Beta
0.80
目标价
17.23
52W 低 2.7352W 高 16.25
价格走势
公司简介
Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; and RAD204, a Nano-mAb PDL1 non-small cell lung the...